Welcome to Alive 2022
A presential and online event, bringing together the latest clinical practices and research material on animal leishmaniosis
A presential and online event, bringing together the latest clinical practices and research material on animal leishmaniosis
SAVE THE DATE | March 31st-April 2nd, 2022
If you want to keep up with the latest news about the event or participate in a more active way, please fill in your details below.
If you want to keep up with the latest news about the event or participate in a more active way, please fill in your details below.
000 days 00 hours 00 minutes 00 seconds
We are looking forward to seeing you in Málaga!
Alive 2022
An International Congress on Animal Leishmaniosis
SAVE THE DATE | March 31st-April 2nd, 2022
Organized by:
LeishVet Sponsors:
These are our goals:
- To share novel research and discoveries on leishmaniosis and to provide a setting to exchange ideas from attendees worldwide.
- To open a forum for individuals and organizations in both public and private sectors (One Health professionals: veterinarians, physicians, biologists, public health authorities).
- To promote multi-disciplinary interactions from basic research to translational clinical or environmental settings.
- To promote a place for deep discussions on solving the problems of animal leishmaniosis.
- To foster international collaboration, industrial participation and training for One Health professionals.
ALIVE 2022 Sponsors:
ALIVE 2022 Donors:
Two streams will be organized:
- Clinical practice oriented stream
- Research oriented stream
ALIVE congress topics will include the following subjects from companion animals to wildlife:
- Epidemiology: vectorial and non-vectorial transmission, Leishmania geographic distribution, infectiousness, etc.
- Basic to clinical immunology.
- Genomics, transcriptomics, proteomics and metabolomics of leishmaniosis, susceptibility and resistance to infection and disease.
- Pathogenesis.
- Clinical and diagnostic aspects.
- Treatment, prognosis and monitoring: old and new treatments, drug resistance, drug development, immunotherapy, new monitoring and prognostic tests.
- Preventative tools: targeting phlebotomine sand flies, host immune response (vaccines, immunomodulators), etc.
